Caribou Biosciences, Inc.CRBUNASDAQ
Loading
CRBU Revenue Growth (YoY Quarterly)•+89.74%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+89.74%
+81.1pp
+0.00%
+22.6pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+4.67%
+1.5pp
+4.67%
+1.5pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -41.62% | -3.13% | -23.01% | +8.60% | +89.74% |
| Gross Profit Growth | -1854.23% | +36.88% | +2.26% | -22.58% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.13% | +3.78% | +2.98% | +3.14% | +4.67% |
| Weighted Average Shares Diluted Growth | +2.13% | +3.78% | +2.98% | +3.14% | +4.67% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -15.76% | -24.16% | -4.66% | -22.33% | -8.37% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -27.51% | -32.73% | -40.77% | -43.37% | -42.67% |
| Book Value per Share Growth | -32.77% | -39.03% | -48.04% | -51.09% | -53.86% |
| Debt Growth | -2.29% | -9.10% | -9.58% | -8.52% | +2.79% |
| R&D Expense Growth | -2.61% | +5.16% | -21.95% | -26.36% | -21.83% |
| SG&A Expenses Growth | +35.38% | -33.52% | -2.13% | -12.96% | -24.70% |
1 / 4